White, James R. (Active Spectrum 201612 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Bruker (Group) |
United States (USA) |
Whitehead, Carlene (Danaher 201204 European MarCom Specialist at Molecular Devices UK) |
Public Relations Manager / Investor Relations Manager |
Danaher (Group) |
United Kingdom (GB) |
Whitmire, Jason D. (BY Capital 201509– Managing Director) |
Managing Partner (investment firm) |
BY Capital (BlueYard Capital) (Group) |
Germany |
Whitson, Todd (Karius 201706– CCO before CareDx + Ariosa Diagnostics + Genzyme Genetics) |
Chief Commercial Officer (CCO) |
Karius Inc. |
United States (USA) |
Wibbelmann, Jobst (Wuesthoff & Wuesthoff 200809 Munich) |
n. a. |
Wuesthoff & Wuesthoff Patent- und Rechtsanwälte (Munich) |
Germany |
Wichert, Burkhard (Baxter 201302 Managing Director of Baxter Oncology GmbH) |
Managing Director |
Baxter (Group) |
Germany |
Wichert, Christian (Evolva 202202– CEO before Johson Matthey + Innovative Water Care) |
Chief Executive Officer (CEO) |
Lallemand (Group) |
Switzerland |
Wichert, Sven (Systasy Bioscience GmbH 201405 Managing Director + Co-Founder) |
Managing Director |
Systasy Bioscience GmbH |
Germany |
Wick, Wolfgang (Univ Heidelberg 201410 Professor + Chair of Neurology Clinic) |
Professor |
University of Heidelberg (Ruperto Carola) |
Germany |
Wicke, Ilka (Boehringer 201203 Director at Boehringer Ingelheim Venture Fund) |
Investment Manager |
Boehringer Ingelheim (Group) |
Germany |
Wicki, Andreas (HBM Healthcare Investments 201402 CEO) |
Chief Executive Officer (CEO) |
HBM (Group) |
Switzerland |
Wicklandt, Petra (Merck (DE) 201801– Head of newly created Corporate Affairs unit joined Merck 1994) |
Business Manager |
Merck (DE) (Group) |
Germany |
Wicks, Frank (SAFC 200610 President) |
n. a. |
Merck (DE) (Group) |
United States (USA) |
Widdowson, Caroline (Schauenburg 201412 promoted Produt Marketing Manager Thermal Desorption at Markes) |
Sales Manager / Marketing Manager |
Schauenburg (Group) |
United Kingdom (GB) |
Widera, Ludwig Nicolaus (Katana Labs 202306– Managing Director + Co-Founder) |
Managing Director |
Katana Labs GmbH |
Germany |
Widmaier, Simon (faCellitate 202209 Managing Director + Co-Founder) |
Managing Director |
faCellitate GmbH |
Germany |
Widmann, Rudolf (AOP Orphan Pharmaceuticals AG 201110 CEO) |
Chief Executive Officer (CEO) |
Élan (Group) |
Austria |
Widmann, Thomas |
n. a. |
Johnson & Johnson (JnJ) (Group) |
Switzerland |
Wiech, Hans (Camoleon Knowledge Brokerage 201108) |
n. a. |
|
|
Wiechmann, Volker (Medways e. V. 201112 Managing Director) |
Managing Director |
Medways e. V. |
Germany |
Wiedemann, Mathias (Wacker 202501– President of Wacker Biosolutions joined Wacker in 2011) |
President/Director/Head Business Group/Unit/Division |
Wacker (Group) |
Germany |
Wiedemann, Sonja (Eurofins 201801 Managing Director at Eurofins Genomics GmbH) |
Managing Director |
Eurofins (Group) |
Germany |
Wiedenfels, Matthias (BioCopy 2023Q4– CEO formerly CEO of Stada Arzneimittel AG) |
Chief Executive Officer (CEO) |
BioCopy (Group) |
Switzerland |
Wiedey, Klaus (Manipal 201403 Managing Director of Ecron Acunova GmbH) |
Managing Director |
Manipal (Group) |
Germany |
Wiedow, Oliver (Proteo Biotech 201411 Director of Proteo Inc) |
President/Director/Head Business Group/Unit/Division |
Proteo Biotech (Group) |
United States (USA) |
Wiegeler, Nikola (Immatics 201708 Media Relations) |
Public Relations Manager / Investor Relations Manager |
Immatics (Group) |
Germany |
Wiegelmann, Alexander M. (KWS 2020 Head of Transactions) |
Business Development Manager / Strategy Manager |
KWS Saat (Group) |
Germany |
Wiegman, Al (Fresenius 201911 Head of Ventures at FMCV) |
Investment Manager |
Fresenius (Group) |
Germany |
Wiehler, Klaus (Sierra Sensors 201010 Managing Director) |
Managing Director |
Bruker (Group) |
Germany |
Wieland, Robert (Wieland Capital 201811 Managing Partner before CSFB + DLJ + Bayer) |
Managing Partner (investment firm) |
Wieland Capital GmbH & Co. KG |
Germany |
Wieloch, Peter (Ingenium Medical Diagnostics 202012 Managing Director + Co-Founder) |
Managing Director |
Ingenium Digital Diagnostics GmbH |
Germany |
Wienand, Wolfgang (Lonza 202407c– CEO before Siegfried since 2010 before Evonik Industries) |
Chief Executive Officer (CEO) |
Lonza (Group) |
Switzerland |
Wienhold, Daniel (Deutsche Bank 201701 Head of Expert Team Life Sciences joined 200808 before IDT Biologika) |
n. a. |
Deutsche Bank (Group) |
Germany |
Wieschaus, Eric (European Molecular Biology Laboratory, 201503) |
n. a. |
EMBL (European Molecular Biology Laboratory) |
Germany |
Wiese, Hanns-Peter (Global Life Science Ventures 201105 Managing Director) |
Managing Director |
Global Life Science Ventures (Group) |
Germany |
Wiesel, Philippe (AgomAb Therapeutics 202103– CMO before Genkyotex + Serono in US + CH) |
Chief Medical Officer (CMO) |
Asahi Kasei (Group) |
Switzerland |
Wieser, Jochen (Optimare 201003 Dept of Science) |
Researcher (industry) |
Aerodata (Group) |
Germany |
Wiesler, Armin (Boehringer 202410– Managing Director Animal Health Business Unit joined 2008) |
Managing Director |
Boehringer Ingelheim (Group) |
Germany |
Wiesmüller, Karl-Heinz (EMC microcollections CEO) |
Chief Executive Officer (CEO) |
EMC microcollections GmbH |
Germany |
Wiessner, Christoph (Asceneuron 201509 COO) |
Chief Operating Officer (COO) |
Asceneuron S.A. |
Switzerland |
Wiest, Christian (iThera Medical 201110 Managing Director) |
Managing Director |
iThera Medical GmbH |
Germany |
Wiest, Joachim (Cellasys GmbH 201201 Managing Director) |
Managing Director |
Cellasys GmbH |
Germany |
Wiest, Kajo (Humedics 202302 Manager Finance + Controlling) |
Chief Financial Officer (CFO) |
Humedics GmbH |
Germany |
Wiestler, Otmar D. (Helmholtz 201211 Head of DKFZ) |
President/Director/Head Business Group/Unit/Division |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
Wiestler, Otmar D. (Helmholtz 202306 President of Helmholtz Association) |
President/Director/Head of Research Organisation/Unit |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
Wigerinck, Piet (Galapagos 201304 CSO before SVP Developm before Tibotec) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Galapagos (Group) |
Belgium |
Wiggenhorn, Michael (Coriolis Pharma 2008– Managing Director + Co-Founder) |
Managing Director |
Coriolis Pharma (Group) |
Germany |
Wiggenhorn, Thomas (Coriolis Pharma 2008– Managing Director + Co-Founder) |
Managing Director |
Coriolis Pharma (Group) |
Germany |
Wiggins, Dale (Philips 201810 Business Leader HealthSuite Digital Platform) |
Product Manager (personnel) |
Philips (Group) |
Netherlands |
Wijlands, Bram (Max Planck 202412 Managing Director at Max Planck Innovation GmbH) |
Managing Director |
Max Planck Society for the Advancement of Science |
Germany |
Wijn, Annemieke |
n. a. |
Kraft Foods (Group) |
Germany |
Wiklund, Fredrik (Bright Peak Therapeutics 202406 CEO) |
Chief Executive Officer (CEO) |
Bright Peak Therapeutics AG |
Switzerland |
Wiklund, Jesper P. (Index Pharmaceuticals 201109– CEO before Sobi before Affectis + Evotec OAI + DeveloGen + Elan) |
Chief Executive Officer (CEO) |
InDex Pharmaceuticals (Group) |
Sweden |
Wilbur, Christina (Roche 201603– Head of Global Human Resources + Member of Corp Executive Committe joined Roche 2002) |
Human Resources Manager |
Roche (Group) |
Switzerland |
Wilcke, Ulf |
n. a. |
Sparkassen-Finanzgruppe (DE) [FICTIVE UNIT, NOT OFFICIAL GROUP!] (Group) |
Germany |
Wilckens, Thomas (InnVentis 201409) |
n. a. |
InnVentis Ltd. |
Germany |
Wild, Alexander (Innerspace 202111 Managing Director) |
Managing Director |
Innerspace GmbH |
Austria |
Wild, Anthony H. (Bows Pharmaceuticals AG 200610– General Partner before MedPointe Pharma CEO before Warner-Lambert) |
General Partner (venture partner) |
Bows Pharmaceuticals AG |
Switzerland |
Wild, Hanno (Bayer 201312 SVP + Head Candidate Generation + Exploration at Bayer HealthCare Global Drug Discovery) |
Research & Development Manager |
Bayer (Group) |
Germany |
Wild, Hans-Peter (Wild Group 201509 Owner + Chairman) |
Board member |
Wild Group (Group) |
|
Wildanger, Oliver (Genetics Company 200512) |
n. a. |
Genetics Company Inc., The |
Switzerland |
Wilde, Lars Christian (Compass Pathways 202004 CBO + Co-Founder) |
Chief Business Officer (CBO) |
Compass Pathways (Group) |
United Kingdom (GB) |
Wilde, Matthias (Sachsen (govt) 202207 Saxony Trade + Invest Life Sciences) |
Trade Promotion Manager / Regional Business Development Manager |
Saxony (govt region) |
Germany |
Wilde, Sandra (Formo Bio 202409 VP of Food) |
n. a. |
Formo Bio (Group) |
Germany |
Wilden, Peter (PolyPeptide 202304 Executive Chair) |
Board member |
PolyPeptide (Group) |
Switzerland |
Wilhelm, Andreas (Tecan 2012 promoted General Counsel + Management Board Member before Head Legal Affairs) |
General Counsel / Chief Legal Officer (CLO) |
Tecan (Group) |
Switzerland |
Wilhelm, Olaf Georg (Therawis 201405– Managing Director before Wilex 2001–201403 CEO) |
Chief Executive Officer (CEO) |
Therawis (Group) |
Germany |
Wilhelmsson, Claes |
Investment Manager |
Investor AB (Wallenberg) (Group) |
Sweden |
Wilkens, Jochen (Chemie Nord 201010 Managing Director) |
Managing Director |
Chemie Nord – Arbeitgeberverband für die Chemische Industrie in Norddeutschland e. V. |
Germany |
Wilkes, Christian H. (PL Bioscience 202408 CFO + Co-Founder) |
Chief Financial Officer (CFO) |
PL BioScience GmbH |
Germany |
Wilkinson, Malcolm (Kirkstall 201802 CEO) |
Chief Executive Officer (CEO) |
Kirkstall (GB) |
United Kingdom (GB) |
Wilkinson, Michael (MiniFAB 201906 Executive Director + acting CEO) |
Chief Executive Officer (CEO) |
Schott (Group) |
Australia |
Wilks, Chris (Sonic Healthcare 201701 CFO + Finance Director) |
Chief Financial Officer (CFO) |
Sonic Healthcare (Group) |
Australia |
Willbold, Dieter (Univ Düsseldorf + FZ Jülich 202102 Prof + Co-Founder of Priavoid) |
Professor |
University of Düsseldorf (Heinrich-Heine-Universität) |
Germany |
Willems, Frank (NonWoTecc Medical 201107 Managing Director) |
Managing Director |
NonWoTecc Medical GmbH |
Germany |
Williams, Antony (RSC 200905– VP Strategic Development before ChemZoo 200804 President) |
n. a. |
Royal Society of Chemistry, The (RSC) |
United Kingdom (GB) |
Williams, David (Nanna Therapeutics 202004 CEO before Discuva) |
Chief Executive Officer (CEO) |
Astellas (Group) |
United Kingdom (GB) |
Williams, James (Siemens 201304 CEO of Siemens Molecular Imaging business unit) |
Chief Executive Officer (CEO) |
Siemens (Group) |
Germany |
WIlliams, Jeff (Clinipace 201504 CEO) |
Chief Executive Officer (CEO) |
Clinipace (Group) |
United States (USA) |
Williams, Jeff (NeuMoDx 201809 CEO) |
Chief Executive Officer (CEO) |
NeuMoDx Moleuclar Inc. |
United States (USA) |
Williams, Jon (Aquapharm Biodiscovery 201207 VP Commercial) |
Chief Commercial Officer (CCO) |
Aquapharm Biodiscovery Ltd. |
United Kingdom (GB) |
Williams, Lewis T. (Five Prime –200910– Founder + Executive Chairman) |
Company Founder |
Five Prime Therapeutics, Inc. (Nasdaq: FPRX) (FivePrime) |
United States (USA) |
Williamson, Anna (Roche 202106 Executive Director Business Development + Head UK BusDev at Roche/Genentech) |
Business Development Manager / Strategy Manager |
Roche (Group) |
Switzerland |
Willing, Lydia (BioEcho 202209– General Manager of BioEcho Life Sciences Inc.) |
General Manager (management) |
BioEcho (Group) |
United States (USA) |
Willinger, Peter (Apogenix 201506– CFO before Sygnis Pharma + Lion Bioscience) |
Chief Financial Officer (CFO) |
Apogenix AG |
Germany |
Willinger, Thomas R. (ZFHN Zukunftsfonds Heilbronn 201105 Managing Director) |
Managing Director |
Zukunftsfonds Heilbronn (Group) |
Germany |
Willinsky, Brian (PerkinElmer 201403) |
Public Relations Manager / Investor Relations Manager |
PerkinElmer (Group) |
United States (USA) |
Willkommen, Hannelore (NewLab BioQuality 200504– VP Regulatory Affairs before Clearant before Paul Ehrlich Institute) |
Regulatory Affairs Manager |
Charles River (Group) |
Germany |
Willmitzer, Lothar (Max Planck 201006 Managing Director MPI for Molecular Plant Physiology) |
President/Director/Head of Research Organisation/Unit |
Max Planck Society for the Advancement of Science |
Germany |
Willms, Andrea (Norgenta 200602) |
n. a. |
Hamburg (govt region) |
Germany |
Wills, Robert J. (Rob) (at JnJ 25 years before Roche) |
Board member, non-executive |
Johnson & Johnson (JnJ) (Group) |
United States (USA) |
Wilmanns, Max (GSK Stockmann 201704 Lawyer + Partner at Hamburg Office) |
Attorney / Lawyer |
|
|
Wilson, Charles (Chuck) (Novartis 201204 Global Head Strategic Alliances before Archemix + Univ California Santa Cruz) |
Business Development Manager / Strategy Manager |
Novartis (Group) |
Switzerland |
Wilson, Dow R. (Varian Medical Systems 201412 CEO) |
Chief Executive Officer (CEO) |
Varian Medical Systems (Group) |
United States (USA) |
Wilson, Julia (Achilles Therapeutics 202011 Head of Communications + JW Communications 201209– before Vectura Group) |
Public Relations Manager / Investor Relations Manager |
JW Communications Ltd. |
United Kingdom (GB) |
Wilson, O’Patrick (O Public Relations 202302 Managing Partner + Owner before Syngenta + Ciba Specialty Chemicals) |
Managing Partner |
O Public Relations GmbH |
Germany |
Wilton, Jane (Philogen SpA 201510 Director Business Development) |
Business Development Manager / Strategy Manager |
Philogen (Group) |
Italy |
Wimmer, Bartl (Synlab 201408 Managing Director) |
Managing Director |
Synlab (Group) |
Germany |
Wimmer, Bernhard (BioM AG 200603) |
Investment Manager |
Bavaria (govt region) |
Germany |
Wimmer, Sylvia (Heidelberg Pharma 202203 Corporate Communciations formerly Wilex 201403 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Heidelberg Pharma (Group) |
Germany |